INOGEN INC (INGN)
US45780L1044 - Common Stock
Overall INGN gets a fundamental rating of 2 out of 10. We evaluated INGN against 192 industry peers in the Health Care Equipment & Supplies industry. INGN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. INGN is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year INGN has reported negative net income.
In the past year INGN has reported a negative cash flow from operations.
INGN had negative earnings in 4 of the past 5 years.
In multiple years INGN reported negative operating cash flow during the last 5 years.
1.2 Ratios
With a Return On Assets value of -31.38%, INGN perfoms like the industry average, outperforming 44.27% of the companies in the same industry.
Looking at the Return On Equity, with a value of -49.98%, INGN is in line with its industry, outperforming 48.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.38% | ||
| ROE | -49.98% | ||
| ROIC | N/A |
ROA(3y)-17.8%
ROA(5y)-9.99%
ROE(3y)-26.63%
ROE(5y)-15.09%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
INGN has a worse Gross Margin (40.12%) than 66.15% of its industry peers.
In the last couple of years the Gross Margin of INGN has declined.
INGN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 40.12% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.59%
GM growth 5Y-4.25%
2. Health
2.1 Basic Checks
INGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, INGN has more shares outstanding
The number of shares outstanding for INGN has been increased compared to 5 years ago.
There is no outstanding debt for INGN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
Based on the Altman-Z score of 0.97, we must say that INGN is in the distress zone and has some risk of bankruptcy.
INGN's Altman-Z score of 0.97 is in line compared to the rest of the industry. INGN outperforms 49.48% of its industry peers.
There is no outstanding debt for INGN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.97 |
ROIC/WACCN/A
WACC10.08%
2.3 Liquidity
INGN has a Current Ratio of 2.86. This indicates that INGN is financially healthy and has no problem in meeting its short term obligations.
INGN has a Current ratio (2.86) which is comparable to the rest of the industry.
INGN has a Quick Ratio of 2.55. This indicates that INGN is financially healthy and has no problem in meeting its short term obligations.
INGN's Quick ratio of 2.55 is in line compared to the rest of the industry. INGN outperforms 53.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.86 | ||
| Quick Ratio | 2.55 |
3. Growth
3.1 Past
The earnings per share for INGN have decreased strongly by -115.11% in the last year.
INGN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.33%.
INGN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.49% yearly.
EPS 1Y (TTM)-115.11%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-470%
Revenue 1Y (TTM)-16.33%
Revenue growth 3Y0.77%
Revenue growth 5Y-2.49%
Revenue growth Q2Q-13.85%
3.2 Future
INGN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.30% yearly.
INGN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.18% yearly.
EPS Next Y14.77%
EPS Next 2Y15.45%
EPS Next 3Y11.3%
EPS Next 5YN/A
Revenue Next Year2.1%
Revenue Next 2Y3.36%
Revenue Next 3Y4.18%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for INGN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for INGN. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.45%
EPS Next 3Y11.3%
5. Dividend
5.1 Amount
No dividends for INGN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
INOGEN INC
NASDAQ:INGN (4/26/2024, 7:00:02 PM)
After market: 6.78 0 (0%)6.78
+0.3 (+4.63%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap158.18M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.38% | ||
| ROE | -49.98% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 40.12% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.97
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.86 | ||
| Quick Ratio | 2.55 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-115.11%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y14.77%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-16.33%
Revenue growth 3Y0.77%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y